Chase Coleman’s Doximity DOCS Stock Holding History

Chase Coleman’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-750,000	Closed	-$37.6M	–	110
2021 Q4	$37.6M	Hold	750,000	–	–	0.08%	82
2021 Q3	$60.5M	Hold	750,000	–	–	0.12%	72
2021 Q2	$43.6M	Buy	+750,000	New	+$42.1M	0.08%	78

Other funds holding DOCS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Chase Coleman's DOCS Position: Q1 2022 in Review

Chase Coleman sold out of Doximity (DOCS) in Q1 2022, closing a stake of 750,000 shares — an estimated $37.6M sold.

Chase Coleman first reported a position in DOCS in Q2 2021 and held it in 3 quarters. The position peaked at $60.5M in Q3 2021. 217 funds tracked by Wall St. Rank hold DOCS as of Q1 2022.

Chase Coleman reported no remaining Doximity position as of Q1 2022 after selling out during the quarter.
Chase Coleman sold 750,000 Doximity shares in Q1 2022, an estimated $37.6M.
Chase Coleman first reported a position in Doximity in Q2 2021 and held it in 3 quarters.
Chase Coleman's Doximity position peaked at $60.5M in Q3 2021.
217 funds tracked by Wall St. Rank held Doximity as of Q1 2022.

Based on Tiger Global Management's 13F filing for Q1 2022, filed 16 May 2022.